{"slug":"soleno-therapeutics","name":"Soleno Therapeutics","url":"https://www.gp-intel.com/company/soleno-therapeutics","sector":"Biotech","country":"US","hq_city":null,"website":"https://soleno.life","founded_year":null,"ipo_year":null,"status":"exited","current_owner":null,"current_holder":{"name":"Neurocrine Biosciences","names":["Neurocrine Biosciences"],"since_year":2026,"basis":"trade_sale"},"ownership_periods":1,"ownership":[{"owner":"Abingworth","fund":"Abingworth Bioventures VI","fund_vintage":2014,"entry_year":2018,"exit_year":2026,"is_exit":true,"deal_type":"Trade Sale","buyer":"Neurocrine Biosciences","moic":null,"sector":"Biotech"}],"source":"gp-intel.com","license":"CC-BY-4.0","updated_at":"2026-07-08T20:41:20.668Z"}